Announcement Avidity biosciences inc, a leading biopharmaceutical company dedicated to provide a new class of RNA therapeutics known as antibody oligonucleotide conjugates (AOCs) have closed its last introduced underwritten public offering of 17,250,000 shares of its common stock consisting of 2,...
Announcement Three new members have joined Aegis Venture’s digital consortium as the health sector seeks strong partnerships to establish and adopt artificial intelligence-fueled health tech solutions, also to address common pain points. Keck Medicine of USC, Hartford Healthcare, and Yale N...
Images Credits: AscellaHealth, LLC Announcement CHAPPER Healthcare, as a ascellahealth’s leading pharmaceutical wholesaler, commercialization, and distributor service provider, predicts its presidency of EUROPACCESS, a smart joint venture of seven pharmaceutical service providers throughou...
Image Credits: Ophthalmology Times Announcement Viridian Therapeutics Inc., a leading biotechnology company committed to developing, commercializing, and exploring capable medicines for rare and serious diseases, has completed the enrollment process in REVEAL-1 and REVEAL-2. These are the phase ...
Image Credits: Springer Announcement Fujifilm Healthcare Europe, the imaging specialist, and the research and training institute IRCAD France have entered a partnership to concentrate on research programs and surgical education. The collaboration will include the company enabling 3D surgical pla...
Announcement UBS AM is a patent business unit of UBS Asset Management Americas LLC, lessening its holdings in shares of HCA Healthcare, Inc. by 0.9% in the first quarter, as recorded in the company’s current filing with the SEC. The institutional investor is the owner of 1,659,647 shares of...
Image Credits: Fierce Healthcare Announcement Samsung e; Electronics has been finalized as the first-ever domestic tech company to join in reshaping the future of the healthcare sector through the healthcare program highlighted by US President Donald Trump. Samsung has long been involved in the ...
Image credits: Optometry Times Announcement Galimedix Therapeutics Inc., a leading phase 2 clinical stage biotechnology company establishing topical neuroprotective and novel therapies with the capability of introducing an evolving change in the treatment of retinal and serious brain disease, co...
Announcement The smartee denti-technology, a leading innovator in introducing invisible orthodontic solutions alongside Shanghai Ninth People’s Hospital associated with Shanghai Jiao Tong University School of Medicine, has received the first prize at the Shanghai Science and Technology Prog...
Image Credits: IdeaUsher Announcement By the end of July number of health systems, health technology, and technology-skilled companies stepped forward to sign on to the CMS-introduced pledges to ‘make health tech great again’. The pledges aim to achieve compassionate goals, including...
